Vaxart, Inc.·4

Mar 5, 4:03 PM ET

Latour Wouter 4

4 · Vaxart, Inc. · Filed Mar 5, 2021

Insider Transaction Report

Form 4
Period: 2021-03-04
Latour Wouter
DirectorPresident and Chief Executive
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-04$0.77/sh+150,000$115,500150,000 total
  • Sale

    Common Stock

    2021-03-04$6.04/sh150,000$906,4500 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-04150,000213,261 total
    Exercise: $0.77Exp: 2029-05-11Common stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.

Documents

2 files